← All trials
NCT03095599
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 20, 2017
- Primary completion
- Jun 1, 2017
- Completion date
- Dec 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 888
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Institute of Vaccines and Medical Biologicals, VietnamLead sponsor
- World Health OrganizationCollaborator
- IQVIACollaborator
- Institut PasteurOverall official - principal investigator
- Institut PasteurCollaborator
- PATHCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.